December 1, 2013 – CPE Program Resources

   gurleyHerbal Dietary Supplements: The Good, the Bad, and the Ugly.

ACPE# 0004-0000-13-373-L01-P                  1.5 Contact Hours
This CPE activity will be knowledge based.

Presented by Bill Gurley, BS, PhD – Professor of Pharmaceutical Sciences, UAMS

Handouts

 

 At the completion of this CPE activity, participants were be able to:

  • Explain the prevalence of dietary supplement usage in the U.S.
  • Describe safety and efficacy issues associated with dietary supplements.
  • List dietary supplements can interact with conventional medications.
  • Recognize clinically relevant herb-drug interactions.
  • Recognize clinical evidence that commonly used botanical supplements can modulate the activities of drug metabolizing enzymes and transporters

Important Links

Suggested Readings

  • Gurley BJ. Clincal pharmacology and dietary supplements: an evolving relationship. Clin. Pharmacol. Ther. 2010;87:235-38
  • Gurley BJ. Pharmacokinetic herb-drug interactions (Part 1): Origins, mechanisms, and the impact of botanical dietary supplements. Planta Medica. 2012;78:1478-1489.
  • Gurley BJ. Pharmacokinetic herb-drug interactions (Part 2): Drug interactions involving popular botanical dietary supplements and their clinical relevance. Planta Medica. 2012;78:1490-1514.
  • Foster L, et al.  Multiple dosing of ephedra-free supplements: hemodynamic, electrocardiographic and bacterial contamination effects. Clin. Pharmacol. Ther. 2013;93:267-274.

mccainK2, Bath Salts & Beyond: Recent Trends in Psychoactive Substance Abuse

ACPE# 0004-0000-13-374-L01-P                  1.5 Contact Hours
This CPE activity will be knowledge based.

Presented by Keith McCain, PharmD, DABAT, CSPI – Assistant Professor, UAMS

Handouts

 At the completion of this CPE activity, participants were be able to:

  • Identify current trends in psychoactive substance abuse.
  • Explain the pharmacology of new psychoactive substances.
  • Describe potential clinical effects and medical interventions related to new psychoactive substance toxicity.
  • Identify regulatory challenges posed by the new psychoactive substances.

Important Links

American Association of Poison Control Centers: www.aapcc.org

www.deadiversion.usdoj.gov/drug_chem_info/index.html

www.unodc.org/documents/scientific/NPS_2013_SMART.pdf

www.erowid.org

www.aapcc.org

www.torproject.org  

www.ecstasydata.org

www.drugs‐forum.com

www.bryanlewissaunders.org/drugs/

www.emcdda.europa.eu

www.gov.uk/government/organisations/advisory‐council‐on‐the‐misuse‐of‐drugs

http://www.mixmag.net/words/features/mixmags‐global‐drug‐survey‐the‐results

References

 

thomasThe Role of the Pharmacist in Stroke Prevention

ACPE# 0004-0000-13-375-L01-P                  1.0 Contact Hours
This CPE activity will be knowledge based.

Presented by Jeremy Thomas, PharmD – Associate Professor, UAMS

Handouts   

 

At the completion of this CPE activity, participants were be able to:

  • Describe the impact of stroke in Arkansans.
  • Identify risk factors for stroke.
  • Describe the role of the pharmacist in minimizing stroke risk.

Important Links

Arkansas Department of Health

Tobacco Prevention and Cessation Program  

Crumbaugh_webImmunization Practices for Community/Retail Pharmacies

ACPE# 0004-0000-13-376-L01-P                  2.0 Contact Hours
This CPE activity will be knowledge based.

Presented by Eric Crumbaugh, PharmD – Immunization Grant Coordinator, APA

Handouts  

 
At the completion of this CPE activity, participants were be able to:

  • Identify the appropriate routine immunizations indicated for an adult patient based on age and medical conditions as recommended by the Centers for Disease Control and Prevention
  • Be able to screen patients for precautions and contraindications to specific vaccines
  • Evaluate strategies to identify patients at increased risk for vaccine-preventable disease.
  • Apply current Advisory Committee on Immunization Practices (ACIP) recommendations to adult patients regarding the administration of Tdap, Pneumonia, and Zoster
  • Discuss insurance coverage and billing procedures of pharmacist-administered immunizations

Important Links

Vaccinnes & Immunizations – http://www.cdc.gov/vaccines/default.htm

Immunization Schedules – http://www.cdc.gov/vaccines/schedules/index.html

Recommendations & Guidelines – http://www.cdc.gov/vaccines/recs/default.htm

Vaccines & Preventable Diseases – http://www.cdc.gov/vaccines/vpd-vac/default.htm